Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Friday broker round-up

Fri, 20th Dec 2019 12:28

(Sharecast News) - Segro: HSBC downgrades to hold with a target price of 869p.

Purplebricks: Peel Hunt reiterates add with a target price of 130p.

Diageo: Credit Suisse reiterates outperform with a target price of 3,570p.

Synthomer: Deutsche Bank reiterates buy with a target price of 410p.

AstraZeneca: Barclays reiterates overweight with a target price 8,300p.

GlaxoSmithKline: Barclays reiterates equal weight with a target price of 1,650p.

Reckitt Benckiser Group: Goldman Sachs reiterates neutral with a target price 6,300p.

Halma: Jefferies reiterates hold with a target price of 2,040p.

TUI: HSBC reiterates hold with a target price of 1,040p.

Senior: JP Morgan reiterates hold with a target price of 180p.

Related Shares

More News

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...